3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
107
Lymphoma
48
Lymphoma, Non-Hodgkin
44
Hodgkin Disease
44
Leukemia, Myeloid, Acute
41
Myelodysplastic Syndromes
40
Leukemia
34
Precursor Cell Lymphoblastic Leukemia-Lymphoma
33
Leukemia, Lymphocytic, Chronic, B-Cell
28
Lymphoma, Mantle-Cell
26
Neoplasms, Plasma Cell
25
Lymphoma, Large B-Cell, Diffuse
24
Lymphoma, Follicular
24
Lymphoma, B-Cell, Marginal Zone
18
Burkitt Lymphoma
18
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
17
Myeloproliferative Disorders
16
Recurrence
14
Immunoglobulin Light-chain Amyloidosis
14
Congenital Abnormalities
13
Primary Myelofibrosis
12
Lymphoma, Large-Cell, Immunoblastic
12
Leukemia, Myeloid, Accelerated Phase
12
Hematologic Neoplasms
12
Waldenstrom Macroglobulinemia
10
Lymphoma, T-Cell, Cutaneous
10
Leukemia, Myelomonocytic, Juvenile
10
Leukemia, Myelomonocytic, Chronic
10
Leukemia, Myeloid, Chronic-Phase
10
Dendritic Cell Sarcoma, Interdigitating
10
Interventions
Rituximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Opsoclonus-Myoclonus Syndrome
×
Melphalan
×
Clear all
No trials found.